Fidelity Investments’s Lifecore Biomedical LFCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$25.5K Buy
3,139
+722
+30% +$5.86K ﹤0.01% 4195
2025
Q1
$17K Buy
2,417
+388
+19% +$2.73K ﹤0.01% 4293
2024
Q4
$15.1K Buy
2,029
+504
+33% +$3.75K ﹤0.01% 4299
2024
Q3
$7.52K Buy
1,525
+105
+7% +$518 ﹤0.01% 4513
2024
Q2
$7.29K Sell
1,420
-70
-5% -$359 ﹤0.01% 4430
2024
Q1
$7.91K Sell
1,490
-3,615
-71% -$19.2K ﹤0.01% 4350
2023
Q4
$31.6K Buy
5,105
+3,209
+169% +$19.9K ﹤0.01% 3727
2023
Q3
$14.3K Sell
1,896
-297
-14% -$2.24K ﹤0.01% 3971
2023
Q2
$21.2K Buy
2,193
+166
+8% +$1.61K ﹤0.01% 3829
2023
Q1
$7.65K Buy
2,027
+1,921
+1,812% +$7.25K ﹤0.01% 4234
2022
Q4
$687 Sell
106
-333
-76% -$2.16K ﹤0.01% 4708
2022
Q3
$4K Sell
439
-856
-66% -$7.8K ﹤0.01% 4400
2022
Q2
$13K Buy
1,295
+36
+3% +$361 ﹤0.01% 4022
2022
Q1
$15K Buy
+1,259
New +$15K ﹤0.01% 4109
2013
Q4
Sell
-632,536
Closed -$7.72M 2658
2013
Q3
$7.72M Sell
632,536
-1,128,854
-64% -$13.8M ﹤0.01% 2034
2013
Q2
$23.3M Buy
+1,761,390
New +$23.3M ﹤0.01% 1595